Authors: Boccardo, F Rubagotti, A Amoroso, D Mesiti, M Romeo, D Sismondi, P Giai, M Genta, F Pacini, P Distante, V Bolognesi, A Aldrighetii, D Farris, A

Citation: F. Boccardo et al., Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial, J CL ONCOL, 18(14), 2000, pp. 2718-2727